JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.C500024200 on February 18, 2005

J. Biol. Chem., Vol. 280, Issue 14, 14288-14292, April 8, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/14/14288    most recent
C500024200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuji, T.
Right arrow Articles by Kunieda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuji, T.
Right arrow Articles by Kunieda, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Loss-of-Function Mutation in Natriuretic Peptide Receptor 2 (Npr2) Gene Is Responsible for Disproportionate Dwarfism in cn/cn Mouse*

Takehito Tsuji{ddagger} and Tetsuo Kunieda

From the Graduate School of Natural Science and Technology, Okayama University, 1-1-1, Tsushima-naka, Okayama 700-8530, Japan

Received for publication, January 19, 2005


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The achondroplastic mouse is a spontaneous mutant characterized by disproportionate dwarfism with short limbs and tail due to disturbed chondrogenesis during endochondral ossification. These abnormal phenotypes are controlled by an autosomal recessive gene (cn). In this study, linkage analysis using 115 affected mice of F2 progeny mapped the cn locus on an ~0.8-cM region of chromosome 4, and natriuretic peptide receptor 2 (Npr2) gene was identified as the most potent candidate for the cn mutant in this region. This gene encodes a receptor for C-type natriuretic peptide (CNP) that positively regulates longitudinal bone growth by producing cGMP in response to CNP binding to the extracellular domain. Sequence analyses of the Npr2 gene in cn/cn mice revealed a T to G transversion leading to the amino acid substitution of highly conserved Leu with Arg in the guanylyl cyclase domain. In cultured chondrocytes of cn/cn mice, stimulus with CNP did not significantly increase intracellular cGMP concentration, whereas it increased in +/+ mice. Transfection of the mutant Npr2 gene into COS-7 cells also showed similar results, indicating that the missense mutation of the Npr2 gene in cn/cn mice resulted in disruption of the guanylyl cyclase activity of the receptor. We therefore concluded that the dwarf phenotype of cn/cn mouse is caused by a loss-of-function mutation of the Npr2 gene, and cn/cn mouse will be a useful model to further study the molecular mechanism regulating endochondral ossification by CNP/natriuretic peptide receptor B signal.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The skeleton of vertebrates is formed by two different processes, namely intramembranous and endochondral ossifications. The latter process leads to the development of long bones that comprise the appendicular skeleton and vertebrae. During endochondral ossification, mesenchymal cells initially differentiate into chondrocytes, and progress through proliferating, maturating, and hypertrophic stages with strict columnar alignment. Distal hypertrophic chondrocytes then undergo apoptosis and are replaced by trabecular bone. A large number of genes have been implicated in the mechanisms regulating these processes (1), and mutations of these genes often cause skeletal dysplasias with shortened extremities (2, 3).

The natriuretic peptide (NP)1 family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) (4), and three receptors for NPs, including natriuretic peptide receptor A (NPRA), natriuretic peptide receptor B (NPRB), and natriuretic peptide receptor C (NPRC), have been identified in mammals (5–7). NPRA and NPRB consist of extracellular ligand binding, transmembrane, protein kinase homology, and guanylyl cyclase catalytic domains. These receptors mediate ligand signals by producing an intracellular second messenger, cyclic GMP (cGMP) (2). Both ANP and BNP bind to NPRA with high affinity, and CNP prefers binding to NPRB (8). NPRC has a ligand-binding domain and a short cytoplasmic domain that lacks guanylyl cyclase activity and is considered to be involved in NP clearance (7). ANP and BNP mainly reside in the atrium and ventricle, respectively, and act as cardiac hormones that regulate central fluid volume, blood pressure, and the development of cardiovascular tissues (9). On the other hand, CNP gene (Nppc) and NPRB gene (Npr2) expressions have been detected in mice tibial growth plates (10, 11) and in the chondrogenic cell line ATDC5 (12). Since CNP stimulates the longitudinal growth of cultured fetal mouse tibias (13) and CNP-deficient mice develop dwarfism due to impaired endochondral ossification (11), the CNP/NPRB pathway has been considered to be involved in the process of endochondral ossification. However, there is no direct evidence that NPRB effects longitudinal bone growth by regulating endochondral ossification.

The achondroplastic mouse is a mutant strain with an autosomal recessive gene (cn) that arose spontaneously in the AKR/J mouse strain (14). The homozygous (cn/cn) mouse exhibits disproportionate dwarfism with short limbs, short tail, and a domed skull. These phenotypes are distinguishable from normal littermates by 7 days after birth and thereafter gradually become more prominent (15, 16). Histological analyses have revealed that the tibial epiphyseal growth plates of cn/cn mice are thinner than normal mice, and the hypertrophic chondrocyte zone is considerably narrowed (17, 18). These findings suggested that the dwarf phenotype of cn/cn mouse was caused by retarded longitudinal bone growth due to disturbed endochondral ossification. Thus, the cn/cn mouse has been believed to be a useful model for hereditary human skeletal dysplasias. However, the gene responsible for the skeletal abnormalities of the cn/cn mouse has not yet been identified. In this study, we determined the chromosomal localization of the cn locus and identified the causative mutation in the Npr2 gene.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Mice—Heterozygotes (cn/+) of mutant mice were obtained from the Jackson Laboratory, and the strain was maintained by sib mating of heterozygotes. JF1/Ms mice were obtained from the National Institute of Genetics, Mishima, Japan.

Linkage Analysis—F1 mice were generated by mating heterozygous (cn/+) mice with JF1 (+/+) mice, and the F2 progeny was subsequently obtained from intercrossing heterozygous (cn/+)F1 mice. Genomic DNA was extracted from mouse livers by phenol/chloroform extraction. PCR reactions for microsatellite markers proceeded as follows: 35 cycles at 94 °C for 30 s, 55–60 °C for 30 s, and 72 °C for 45 s. The primer sequences of newly generated microsatellite markers, D4Mok1 (5'-GATTTGAGTTTCTGACACCTCCC-3' and 5'-ACTTGCTTGTTTGCGTGTGGGC-3') and D4Mok2 (5'-TCCTTGGCTGATGCCTAAGC-3' and 5'-GGTCTAGGAAGCTAACTCAGTGG-3'), were obtained from genomic sequences located at 42.2 Mb (GenBankTM accession number NT_039260 [GenBank] ) and 43.0 Mb (GenBankTM accession number NT_039296 [GenBank] ) positions on mouse chromosome 4, respectively. The reaction mixture for PCR (10 µl) contained 1x PCR buffer, 0.2 mM dNTP, a 0.5 µM concentration of each primer, and 0.25 unit of TaqDNA polymerase (Amersham Biosciences). The PCR products were fractionated on 3.0% agarose gels and stained with ethidium bromide. The data were analyzed using Map Manager computer software.

Detection of Mutation in Npr2 Gene—Tibial RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. The extracted RNA was then incubated with RNase-free DNase I (Takara, Ohtsu, Japan) for 1 h at 37 °C to remove contaminating genomic DNA. First strand cDNA was synthesized for reverse transcription-PCR using the Superscript preamplification system (Invitrogen) according to the manufacturer's instructions. Npr2 cDNA was amplified with specific primer (5'-TGTATCCGGGCCGACTAAGCTTGC-3 and 5'-GGAAACACAGTGACCATTGCCCATCC-3') under the following conditions: 94 °C for 2 min followed by 35 cycles of 94 °C for 30 s, 64 °C for 20 s, and 72 °C for 4 min. The amplified fragments were sequenced using an ABI PRIZM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA).

To detect the mutation in the genomic DNA of mice by restriction enzyme digestion, DNA fragments, including exon 18 of Npr2 gene, were amplified from genomic DNA using specific primers (5'-TTCACAGCGCTGTCAGCTGAG-3' and 5'-ACTTAGGGAGCGCTGACTGTGG-3'). PCR reaction was carried out as follows: 35 cycles of 94 °C for 30 s, 62 °C for 20 s, and 72 °C for 30 s. The PCR products were digested with AflIII restriction enzyme at 37 °C, and electrophoresed on 3% agarose gel.

Culture of Mouse Chondrocytes and COS-7 Cells—Chondrocytes were prepared from the costal cartilage of cn/cn or +/+ mice (n = 5) at postnatal day 7 as described (19). COS-7 cells were obtained from the RIKEN cell bank (Tsukuba, Japan). These cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine medium, 100 units/ml penicillin, and 100 µg/ml streptomycin at 37 °C under 5% CO2 in air. The chondrocytes were seeded in 12-well multiwell plates, and cGMP levels were measured when the cells reached confluence. The COS-7 cells were plated at a density of 1 x 104 cells/well in 96-well multiwell plates and used for transfection after incubation for 24 h.

Transient Expression of Npr2 Gene in Cultured Cells—Full-length Npr2 cDNA was amplified by reverse transcription-PCR with tibial RNA extracted from cn/cn or +/+ mice using primers containing EcoRI or the NotI site (5'-CGGAATTCTATCGCCATGGCACTGCCATC-3 and 5'-AGCAGAAGGCGGCCGCCCTGGGCTTTACAG-3'). PCR was performed at 94 °C for 2 min followed by 35 cycles of 94 °C for 30 s, 64 °C for 20 s, and 72 °C for 4 min. Amplified fragments were digested with EcoRI and NotI restriction enzyme and then ligated into pcDNA3.1 mammalian expression vector (Invitrogen). The COS-7 cells were transfected with the DNA constructs using FuGENE 6 (Roche Diagnostics), and the transfected cells were subjected to cGMP level measurement after incubation for 24 h.

Measurement of cGMP Levels in Cultured Cells—The cultured cells were washed twice with phosphate-buffered saline, and incubated in Dulbecco's modified Eagle's medium containing 0.1% fetal bovine serum and 0.5 mM 3-isobutyl-1-methylxanthine at 37 °C for 15 min. Thereafter, various concentrations of CNP were added to the medium, and the incubation proceeded at 37 °C for a further 15 min. The amount of cGMP was measured using a cGMP enzyme immunoassay Biotrak system (Amersham Biosciences).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Mapping the cn Locus by Linkage Analysis—To determine the chromosomal localization of the cn locus by linkage analysis, heterozygous (cn/+) mice were crossed with JF1/Ms (+/+) mice. Heterozygotes (cn/+) of F1 mice were intercrossed, and 483 F2 progeny were obtained, including 115 affected and 368 normal mice. The ratio of affected to normal F2 progeny did not significantly differ from the expected 1:3 distribution of recessive inheritance. We initially examined the linkage between the cn locus and microsatellite markers on entire mouse chromosomes with ~20-cM intervals using the 115 affected mice. Significant linkage was detected between the cn locus and markers on the proximal region of chromosome 4, indicating the localization of the cn locus on this region. To narrow the critical interval of the cn locus, we further genotyped eight markers located at the proximal region of chromosome 4. As shown in Fig. 1A, no recombination was observed between the cn locus and D4Mok1, and at least one recombination was observed with the other markers. These data indicated that the cn locus was mapped on the 0.8-cM interval between D4Mit182 and D4Mit109, D4Mit213, and D4Mit257 (Fig. 1B).



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 1.
Mapping the cn locus by linkage analysis. A, Segregation of the cn locus and flanking microsatellite markers in 115 homozygous (cn/cn) mice of F2 progeny. White and black boxes indicate the homozygote and heterozygote of the cn type allele, respectively. The number of mice with each haplotype is given at the bottom. B, position of the cn locus on mouse chromosome 4. The region of the cn locus is indicated on the linkage map by an arrow, and the distances between each locus are shown to the left of the linkage map. A physical map corresponding to the region of the cn locus is shown on the right. The positions of candidate genes for the cn mutant allele and microsatellite markers are indicated on the right of the physical map.

 
Detection of Mutation in Npr2 Gene—By comparison of the linkage map with the mouse genome sequence, two genes, Npr2 and Rmrp, which are functionally related to the phenotypes of cn/cn mice, were found in the critical region of the cn locus (Fig. 1B). Mutations in human othologues of Npr2 and Rmrp genes have been found in patients with acromesomelic dysplasia Maroteaux type (20) and cartilage-hair hypoplasia (21), respectively. These human disorders are characterized by skeletal dysplasias with disproportionate short stature. Thus, we considered that these genes are the most likely candidate genes for the cn locus. To identify the causative mutation in these genes, we amplified and sequenced the entire coding region of these genes and compared the cn/cn and +/+ mice. The nucleotide sequence of the Rmrp gene showed no causative mutation, and the Rmrp gene was therefore excluded from the candidates. However, sequence analysis of the Npr2 cDNA fragment revealed a T to G transversion leading to an amino acid substitution of Leu to Arg at codon 885 in cn/cn mice (Fig. 2A). We confirmed this mutation by sequencing exon 18 of Npr2 genomic DNA in cn/cn mice (data not shown). To confirm whether the T to G substitution is unique to the cn mutant allele, PCR fragments including exon 18 of the Npr2 gene were amplified from five inbred strains of mice and digested by the AflIII restriction enzyme, for which a recognition site is generated by the T to G substitution. Consequently, a 348-bp fragment amplified from the cn mutant allele was digested with AflIII, whereas the fragments from +/+ and AKR/J, the original strain of cn/cn mouse, as well as other four strains, were not digested (Fig. 2C). These results indicated that the substitution of T to G in the Npr2 gene is specific to the cn mutant allele.



View larger version (48K):
[in this window]
[in a new window]
  		FIG. 2.
Missense mutation in the Npr2 gene of cn/cn mice. A, nucleotide sequence of the Npr2 gene in cn/cn and +/+ mice. A single nucleotide substitution of T to G leading Leu to Arg substitution on guanylyl cyclase domain was found at nucleotide position 2654 of Npr2 cDNA in cn/cn mice. B, alignment of the deduced amino acid sequences in the guanylyl cyclase domain of NPRB orthologues from vertebrate and invertebrate species. The black boxed area indicates the amino acid position affected by missense mutation in cn/cn mice. Areas shaded gray indicate the conserved sequences. The sources of sequences are as follows: M. musculus (GenBankTM accession number NM_173788 [GenBank] ), Homo sapiens (GenBankTM accession number NM_000907 [GenBank] ), Rattus norvegicus (GenBankTM accession number NM_053838 [GenBank] ), Xenopus laevis (GenBankTM accession number AB025112 [GenBank] ), and Caenorhabditis elegans (GenBankTM accession number NM_058978 [GenBank] ). C, detection of the missense mutation in the Npr2 gene by restriction enzyme analysis. A 348-bp fragment, including the nucleotide substitution of the Npr2 gene of cn/cn mice, was digested by AflIII restriction enzyme, while the fragments of +/+ and AKR/J mice as well as other normal mice were not digested.

 
Effect of the Missense Mutation on Guanylyl Cyclase Activity of NPRB—The Npr2 gene encodes a NPRB, which mediates CNP signals via cGMP production by its intracellular guanylyl cyclase domain. Since Leu at codon 885 on the guanylyl cyclase domain of NPRB is highly conserved among various species (Fig. 2B), this amino acid residue seemed critical for the domain function. To examine the effect of the amino acid substitution of NPRB on guanylyl cyclase activity, we measured the amount of cGMP produced by CNP stimulation in the chondrocytes obtained from the costal cartilage of cn/cn and +/+ mice. The levels of cGMP in the chondrocytes of +/+ mice increased dose-dependently in response to CNP stimulus, whereas the cGMP levels did not significantly change in cn/cn mice (Fig. 3A). Furthermore, we investigated the guanylyl cyclase activity in COS-7 cells transfected with the expression vector containing the mutant or wild-type Npr2 gene. Intracellular cGMP levels obviously increased in COS-7 cells transfected with the wild-type gene after exposure to 10-6 M CNP, but no significant change was observed in COS-7 cells transfected with a mutant gene (Fig. 3B). Western blotting indicated equivalent amounts of NPRB proteins in both cells (data not shown). These results demonstrated that the missense mutation in the Npr2 gene impaired the guanylyl cyclase activity of NPRB.



View larger version (11K):
[in this window]
[in a new window]
  		FIG. 3.
Effect of amino acid substitution on guanylyl cyclase activity of NPRB. A, amount of cGMP in cultured chondrocytes of cn/cn and +/+ mice. The levels of cGMP in the chondrocytes of +/+ mice increased dose-dependently in response to CNP stimulus, while no significant increase of intracellular cGMP level was observed in cn/cn mice. The data are the mean ± S.E. B, amount of cGMP in COS-7 cells transfected with a mutated or normal Npr2 gene. The COS-7 cells transfected with the mutated Npr2 gene (R885) showed an undetectable level of cGMP after 10-6 M CNP stimulus, whereas a remarkable increase of cGMP production was observed in COS-7 cells transfected with the wild-type gene (L885). The data are the mean ± S.E. of 10 wells.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
In this study, we precisely mapped the cn locus on chromosome 4 and identified a missense mutation in the Npr2 gene. This mutation leads to the substitution of highly conserved hydrophobic residues (Leu) with the hydrophilic residue (Arg) in the guanylyl cyclase domain of NPRB. We further confirmed that cGMP was not produced in response to CNP stimulus in cells expressing the mutant Npr2 gene. Therefore, it is likely that the guanylyl cyclase activity of NPRB in cn/cn mouse was disrupted by amino acid substitution in the highly conserved region of the guanylyl cyclase domain. Several lines of evidence have suggested that the Npr2 gene plays a critical role in regulating endochondral ossification. 1) The Npr2 gene is predominantly expressed in the proliferating and prehypertrophic chondrocytes of the epiphyseal growth plate (10, 11); 2) cyclic GMP, as well as CNP, stimulates longitudinal bone growth (22), and mice with a targeted disruption of CNP or cGMP-dependent protein kinase type II, a downstream mediator of cGMP, develop dwarfism due to impaired endochondral ossification (11, 23, 24); 3) mutations in the NPR2 gene have been identified in patients with Acromesomelic dysplasia Maroteaux type, a hereditary human disorder characterized by disproportionate dwarfism (20). We therefore concluded that the retarded longitudinal bone growth of cn/cn mouse resulted from cGMP deficiency in the chondrocytes during endochondral ossification caused by a loss-of-function mutation in the Npr2 gene.

The cn/cn mice exhibit disproportionate dwarfism with short limbs and tail, and the prominent abnormality during endochondral ossification consists of decreased numbers of proliferating and hypertrophic chondrocytes in a narrowed epiphyseal growth plate (17, 18, 25, 26). These skeletal phenotypes of cn/cn mice are morphologically and histologically very similar to those of CNP-deficient mice (11). In addition, decreased levels of cGMP are detected in both the tailbone of CNP-deficient mice and in cells expressing the mutated Npr2 gene (11). Although CNP not only binds to NPRB with high affinity but also binds NPRA with low affinity (8, 27), NPRA is expressed slightly in mouse tibia (13), and NPRA-deficient mice show no skeletal abnormality (29). Taken together, these findings indicate that the NPRB/cGMP pathway selectively mediates the CNP signal to promote longitudinal bone growth by regulating endochondral ossification.

Although the phenotypes of cn/cn and CNP-deficient mice are similar in terms of gross appearance and in the histological features of tibial growth plate, the survival rates of these mice are quite different. The mortality of CNP-deficient mice is 70% at 100 days of age (11), while that of the cn/cn mice used in this study was less than 10% (data not shown). CNP functions not only in endochondral ossification but also in cardiovascular regulation and vascular tone (30). In addition, CNP has been detected in various tissues such as the brain, spinal cord, heart, kidney, lung, thymus, liver, stomach, uterus, and ovary (31). Thus, the CNP signal, possibly mediated by other receptor(s) including NPRA, might play a role in these tissues other than skeletal tissues. Another possible explanation for this discrepancy in mortality is their distinct genetic backgrounds. Lane and Dickie (14) described that most cn/cn mice used in their study died before 3 months of age. The cn/cn mice used in their study had an AKR/J background, while the cn/cn mice used in this study had a mixed background of C57BL/6J, C3H/HeDiSn, and LG/J (14, 25). Since it is unclear whether cn/cn and the CNP-deficient mice died from the same causes, further studies on the cause of death of cn/cn and the CNP-deficient mice with an identical genetic background would provide a novel function of CNP and/or NPRB in tissues other than in bone growth.

Acromesomelic dysplasia Maroteaux type (AMDM) is an autosomal recessive human disorder characterized by disproportionate short stature and shortening of the extremities (32), but its exact etiology remains unclear because of the lack of a suitable animal model for this disorder. Mutations in the NPR2 gene have recently been identified in affected families, and declined guanylyl cyclase activities of NPRB of mutant alleles have also been observed (20). With respect to the symptoms of AMDM, the disproportionately short limbs become more apparent during childhood than during the postnatal and neonatal periods (33). The skeletal abnormalities of cn/cn mice also became progressively more obvious with age (15, 16). Therefore, cn/cn mouse is a useful model for investigating the pathogenesis and therapeutic approaches of AMDM.

It is apparent that both CNP and cGMP signals play important roles in the regulation of endochondral ossification. However, the precise role of the signal pathway through NPRB during endochondral ossification remains unclear. The cn/cn mouse is the first animal model with a mutated Npr2 gene and can be used to evaluate the physiological function of NPRB. In cn/cn mice, the proliferative activities of proliferating chondrocytes in the epiphyseal growth plate are significantly lower than in control mice (25, 26). The numbers of proliferating and hypertrophic chondrocytes are also severely reduced in cn/cn mice (17, 18). The signal pathway through NPRB therefore appears to positively affect chondrocyte proliferation and differentiation. However, further studies are needed to elucidate how this pathway regulates chondrocyte proliferation and differentiation. Fibroblast growth factor 3 (FGFR3) is a one of the most important factors that negatively regulate the proliferation and differentiation of chondrocytes (34). Mice expressing constitutively activated Fgfr3 histologically exhibit very similar chondrocytic abnormalities in the epiphyseal growth plates to those of cn/cn mice (34). Furthermore, CNP transgenic mice rescue the achondroplastic phenotype of Fgfr3 mutant mice by inhibiting the MAPK pathway through FGFR3, and new therapeutic approaches via the activation of CNP/NPRB have been suggested for the treatment of human achondroplasia (28). Taken together, CNP signals mediated by NPRB might regulate chondrocyte proliferation and differentiation during endochondral ossification through modification of the signal from FGFR3. Further studies using cn/cn mice, as well as CNP-deficient mice, will help to clarify the role of the CNP/NPRB/cGMP pathway in chondrocytes during endochondral ossification and to develop novel therapeutic approaches for human skeletal dysplasias.


   FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 81-86-251-8325; Fax: 81-86-251-8388; E-mail: takehito{at}cc.okayama-u.ac.jp.

1 The abbreviations used are: NP, natriuretic peptide; ANP, atrial NP; BNP, brain NP; NPRA, NP receptor A; NPRB, NP receptor B; NPRC, NP receptor C; CNP, C-type NP; AMDM, acromesomelic dysplasia Maroteaux type. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Erlebacher, A., Filvaroff, E. H., Gitelman, S. E., and Derynck, R. (1995) Cell 80, 371-378[CrossRef][Medline] [Order article via Infotrieve]
  2. Newman, B., and Wallis, G. A. (2003) Clin. Genet. 63, 241-251[CrossRef][Medline] [Order article via Infotrieve]
  3. Cohen, M. M., Jr. (2002) Am. J. Med. Genet. 112, 304-313[CrossRef][Medline] [Order article via Infotrieve]
  4. Levin, E. R., Gardner, D. G., and Samson, W. K. (1998) N. Engl. J. Med. 339, 321-328[Free Full Text]
  5. Chinkers, M., Garbers, D. L., Chang, M. S., Lowe, D. G., Chin, H. M., Goeddel, D. V., and Schulz, S. (1989) Nature 338, 78-83[CrossRef][Medline] [Order article via Infotrieve]
  6. Schulz, S., Singh, S., Bellet, R. A., Singh, G., Tubb, D. J. Chin, H., and Garbers, D. L. (1989) Cell 58, 1155-1162[CrossRef][Medline] [Order article via Infotrieve]
  7. Maack, T., Suzuki, M., Almeida, F. A., Nussenzveig, D., Scarborough, R. M., McEnroe, G. A., and Lewicki, J. A. (1987) Science 238, 675-678[Abstract/Free Full Text]
  8. Suga, S., Nakao, K., Hosoda, K., Mukoyama, M., Ogawa, Y., Shirakami, G., Arai, H., Saito, Y., Kambayashi, Y., Inouye, K., and Imura, H. (1992) Endocrinology 130, 229-239[Abstract]
  9. Cameron, V. A., and Ellmers, L. J. (2003) Endocrinology 144, 2191-2194[Abstract/Free Full Text]
  10. Yamashita, Y., Takeshige, K., Inoue, A., Hirose, S., Takamori, A., and Hagiwara, H. (2000) J. Biochem. (Tokyo) 127, 177-179[Free Full Text]
  11. Chusho, H., Tamura, N., Ogawa, Y., Yasoda, A., Suda, M., Miyazawa, T., Nakamura, K., Nakao, K., Kurihara, T., Komatsu, Y., Itoh, H., Tanaka, K., Saito, Y., Katsuki. M., and Nakao, K. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 4016-4021[Abstract/Free Full Text]
  12. Suda, M., Tanaka, K., Yasoda, A., Komatsu, Y., Chusho, H., Miura, M., Tamura, N., Ogawa, Y., and Nakao, K. (2002) J. Bone Miner. Metab. 20, 136-141[CrossRef][Medline] [Order article via Infotrieve]
  13. Yasoda, A., Ogawa, Y., Suda, M., Tamura, N., Mori, K., Sakuma, Y., Chusho, H., Shiota, K., Tanaka, K., and Nakao, K. (1998) J. Biol. Chem. 273, 11695-11700[Abstract/Free Full Text]
  14. Lane, P. W., and Dickie, M. M. (1968) J. Hered. 59, 300-308[Free Full Text]
  15. Silberberg, R., and Lesker, P. (1975) Growth 39, 17-33[Medline] [Order article via Infotrieve]
  16. Johnson. D. R. (1978) J. Anat. 125, 267-275[Medline] [Order article via Infotrieve]
  17. del Marco, A. (1981) Reprod. Nutr. Dev. 21, 1025-1031[Medline] [Order article via Infotrieve]
  18. Wikstrom, B., Hjerpe, A., Reinholt, F. P., and Engfeldt, B. (1986) Coll. Relat. Res. 6, 279-293[Medline] [Order article via Infotrieve]
  19. Lefebvre, V., Garofalo, S., Zhou, G., Metsaranta, M., Vuorio, E., and De Crombrugghe, B. (1994) Matrix Biol. 14, 329-335[CrossRef][Medline] [Order article via Infotrieve]
  20. Bartels, C. F., Bukulmez, H., Padayatti, P., Rhee, D. K., van Ravenswaaij-Arts, C., Pauli, R. M., Mundlos, S., Chitayat, D., Shih, L. Y., Al-Gazali, L. I., Kant, S., Cole, T., Morton, J., Cormier-Daire, V., Faivre, L., Lees, M., Kirk, J., Mortier, G. R., Leroy, J., Zabel, B., Kim, C. A., Crow, Y., Braverman, N. E., van den Akker, F., and Warman, M. L. (2004) Am. J. Hum. Genet. 75, 27-34[CrossRef][Medline] [Order article via Infotrieve]
  21. Ridanpaa, M., van Eenennaam, H., Pelin, K., Chadwick, R., Johnson, C., Yuan, B., vanVenrooij, W., Pruijn, G., Salmela, R., Rockas, S., Makitie, O., Kaitila, I., and de la Chapelle, A. (2001) Cell 104, 195-203[CrossRef][Medline] [Order article via Infotrieve]
  22. Mericq, V., Uyeda, J. A., Barnes, K. M., De Luca, F., and Baron, J. (2000) Pediatr. Res. 47, 189-193[Medline] [Order article via Infotrieve]
  23. Miyazawa, T., Ogawa, Y., Chusho, H., Yasoda, A., Tamura, N., Komatsu, Y., Pfeifer, A., Hofmann, F., and Nakao, K. (2002) Endocrinology 143, 3604-3610[Abstract/Free Full Text]
  24. Pfeifer, A., Aszodi, A., Seidler, U., Ruth, P., Hofmann, F., and Fassler, R. (1996) Science 274, 2082-2086[Abstract/Free Full Text]
  25. Thurston, M. N., Johnson, D. R., and Kember, N. F. (1985) J. Anat. 140, 425-434[Medline] [Order article via Infotrieve]
  26. Sannasgala, S. S., and Johnson, D. R. (1990) J. Anat. 172, 245-258[Medline] [Order article via Infotrieve]
  27. Koller, K. J., Lowe, D. G., Bennett, G. L., Minamino, N., Kangawa, K., Matsuo, H., and Goeddel, D. V. (1993) EMBO J. 12, 769-777[Medline] [Order article via Infotrieve]
  28. Yasoda, A., Komatsu, Y., Chusho, H., Miyazawa, T., Ozasa, A., Miura, M., Kurihara, T., Rogi, T., Tanaka, S., Suda, M., Tamura, N., Ogawa, Y., and Nakao, K. (2004) Nat. Med. 10, 80-86[CrossRef][Medline] [Order article via Infotrieve]
  29. Lopez, M. J., Wong, S. K., Kishimoto, I., Dubois, S., Mach, V., Friesen, J., Garbers, D. L., and Beuve, A. (1995) Nature 378, 65-68[CrossRef][Medline] [Order article via Infotrieve]
  30. Tokudome, T., Horio, T., Soeki, T., Mori, K., Kishimoto, I., Suga, S., Yoshihara, F., Kawano, Y., Kohno, M., and Kangawa, K. (2004) Endocrinology 145, 2131-2140[Abstract/Free Full Text]
  31. Stepan, H., Leitner, E., Bader, M., and Walther, T. (2000) Regul. Pept. 95, 81-85[CrossRef][Medline] [Order article via Infotrieve]
  32. Maroteaux, P., Martinelli, B., and Campailla, E. (1971) Presse Med. 79, 1839-1842[Medline] [Order article via Infotrieve]
  33. Langer, L. O., and Garrett, R. T. (1980) Radiology 137, 349-355[Abstract/Free Full Text]
  34. Naski, M. C., Colvin, J. S., Coffin, J. D., and Ornitz, D.M. (1998) Development (Camb.) 125, 4977-4988[Abstract]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
P. Moffatt, G. Thomas, K. Sellin, M.-C. Bessette, F. Lafreniere, O. Akhouayri, R. St-Arnaud, and C. Lanctot
Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth
J. Biol. Chem., December 14, 2007; 282(50): 36454 - 36462.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
H. Schmidt, A. Stonkute, R. Juttner, S. Schaffer, J. Buttgereit, R. Feil, F. Hofmann, and F. G. Rathjen
The receptor guanylyl cyclase Npr2 is essential for sensory axon bifurcation within the spinal cord
J. Cell Biol., October 22, 2007; 179(2): 331 - 340.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Hachiya, Y. Ohashi, Y. Kamei, T. Suganami, H. Mochizuki, N. Mitsui, M. Saitoh, M. Sakuragi, G. Nishimura, H. Ohashi, et al.
Intact Kinase Homology Domain of Natriuretic Peptide Receptor-B Is Essential for Skeletal Development
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4009 - 4014.
[Abstract] [Full Text] [PDF]

Home page
 J HeredHome page
C. Sogawa, T. Tsuji, Y. Shinkai, K. Katayama, and T. Kunieda
Short-Limbed Dwarfism: slw Is a New Allele of Npr2 Causing Chondrodysplasia
J. Hered., September 1, 2007; 98(6): 575 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. H. Langenickel, J. Buttgereit, I. Pagel-Langenickel, M. Lindner, J. Monti, K. Beuerlein, N. Al-Saadi, R. Plehm, E. Popova, J. Tank, et al.
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B
PNAS, March 21, 2006; 103(12): 4735 - 4740.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
Endocr. Rev., February 1, 2006; 27(1): 47 - 72.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
P. Krejci, B. Masri, V. Fontaine, P. B. Mekikian, M. Weis, H. Prats, and W. R. Wilcox
Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis
J. Cell Sci., November 1, 2005; 118(21): 5089 - 5100.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/14/14288    most recent
C500024200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuji, T.
Right arrow Articles by Kunieda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuji, T.
Right arrow Articles by Kunieda, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.